Chronic Rhinosinusitis Market ppt

1. Chronic Rhinosinusitis Market Report 2019-2027 www.emergenresearch.com . 2 Adoption of minimally invasive techniques, technological advancements, substantial prevalence of rhinosinusitis with favorable reimbursement scenarios are forecasted to fuel the market growth

2. Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis

3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

4. Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

5. Market Summary The global Chronic Rhinosinusitis Market was valued at USD 2132.5  million in 2019 and is expected to reach USD 3508.0 million by 2027, at a CAGR of 7.4%, According to the current analysis of Emergen Research. Development and manufacture of proficient sinusitis drugs are likely to be highly demanded for efficient treatment of chronic rhinosinusitis as, pollutants, fungal infections and allergies immensely contribute to the rising incidence of rhinosinusitis. Moreover, growing prevalence of growing prevalence of chronic asthma, inflammation of mucosal linings of the nasal passage, and cases of paranasal sinuses are expected to fuel the growth prospects of chronic rhinosinusitis market in the forecast period. Roughly more than 15 million people suffer from chronic symptoms of rhinosinusitis in the United States, that is, prevalence of chronic rhinosinusitis ranges from 1% to 5% of the total US population. Chronic rhinosinusitis is primarily characterized by nasel blockage, inflammation of the sinus and nasel linings, facial pain along with rhinorrhea and loss of sense of smell. Effective treatment includes improvement in sinus outflow, enhancement of mucociliary clearance and elimination of inflammation and local infection among other associated treatments. Additionally, increase in implementation of minimally invasive surgical procedures, widespread awareness concerning the symptoms of the target disease across regions and technological progressions among other favorable scenarios are likely to augment the growth of industry during the period of 2020-2027. However, low preference towards sinus surgical undertakings, post-surgery risks of sinus treatment and high cost of treatment may hinder the growth of chronic rhinosinusitis market in the forecast period. www.emergenresearch.com

6. Market Summary • Further key findings from the report suggest • Xolair (Omalizumab) manufactured by Novartis, was approved in August 2020, by European Commission (EC). The product development is attributed to treat severe chronic rhinosinusitis with nasal polyps. • Due to considerable employability of antibiotics and their effectiveness in efficiently treating chronic rhinosinusitis, antibiotics product segment held largest market share of 41.6% in 2019 and is likely to dominate the industry during 2019-2027 • Immune deficiency disease segment in the disease outlook registered highest CAGR of 7.1% in 2019 whereas, anatomical differences disease segment accounted for largest market share of approximately 37.5% owing to increase in prevalence of target disease across the globe • . • Request Free Sample : https://www.emergenresearch.com/request-sample/74 www.emergenresearch.com

7. Market Summary • Some Key Highlights From the Report • Regeneron Pharmaceuticals and Sanofi’sDupixent (Dupilumab) was approved in June 2019, by US Food and Drug Administration (FDA). This drug is customized for adults with incompetently controlled chronic rhinosinusitis along with nasal polyposis • Owing to favourable reimbursement policies, high prevalence of target disease and technological advancements among other encouraging scenarios North America accounted for largest market revenue with significant market share of 37.2% in 2019 • Key market companies studied and profiled for this research include AstraZeneca, Bayer AG, Ivax Pharmaceuticals, Pfizer, Novartis Pharmaceuticals Corporation, Sanofi, Sunovion Pharmaceuticals, Cipla, Smith & Nephew, Medtronic, SinuSys Corporation, Olympus Corporation and Acclarent among other companies • Request Free Sample Copy@https://www.emergenresearch.com/request-sample/74 www.emergenresearch.com

8. Market Summary • Emergen Research have segmented Chronic Rhinosinusitis Market on the basis of product, disease type, distribution channel and region: • Product Outlook (Revenue in Million USD; 2017–2027) • Nasal Irrigation • Hypertonic and Isotonic Saline • Steroid Nasal Irrigation • Topical Antibiotic Therapy • Antibiotics • Amoxicillin-Clavulanate • Clindamycin • Sulfamethoxazole • Levofloxacin • Macrolide Therapy • Antifungal Therapy • Read More@https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

9. Market Summary • Disease Outlook (Revenue in Million USD; 2017–2027) • Anatomical Differences • Nasal Tumors • Mucosal Edema • Non-Allergic Rhinitis • Immune Deficiency • Other • Distribution Channel (Revenue in Million USD; 2017–2027) • Hospital Pharmacies • Retail Pharmacies • Drug Stores • Other • Read more: https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

10. MARKETSEGMENTATION www.emergenresearch.com

11. Regional Share Dynamics www.emergenresearch.com

12. LATEST PUBLICATIONS Related reports: Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market RNA Transcriptomics Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5 www.emergenresearch.com

13. About Us At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. www.emergenresearch.com

14. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756